Alpine Global Management, LLC C4 Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.05 - $8.1 $232,988 - $465,976
57,528 New
57,528 $265,000
Q4 2022

Feb 14, 2023
BUY
$5.42 - $10.24 $100,671 - $190,197
18,574 New
18,574 $110,000
Q4 2021

Feb 14, 2022
SELL
$29.39 - $46.86 $178,985 - $285,377
-6,090 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$35.91 - $50.5 $218,691 - $307,545
6,090 New
6,090 $244,000

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $170M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email